@misc{indiciae56bab88b16de,
  title = {Pharmacologic inhibition of OLIG2 by CT-179 disrupts mitotic progression and enhances standard-of-care chemoradiotherapy in glioblastoma},
  author = {Greenall, S. A. and Chen, S. C. and Alton, G. and Beaton, G. and Boelter, R. and Casey, M. and Babic, I. and Bruce, Z. C. and Garama, D. J. and Mukthavaram, R. and Tucci, F. C. and Ravula, S. B. and Lopez, A. and Knowles, S. and Stein, G. D. and Li, Y. and Stork, B. and Dsouza, R. C. J. and Kumar, A. and Kittler, R. and Tuma, A. C. M. and Sarkaria, J. N. and Gough, D. J. and Stewart, R. A. and Kesari, S. and Day, B. W. and Johns, T. G.},
  year = {2026},
  doi = {10.64898/2026.10.14.759257},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.14.759257v1},
  note = {Source identifier: 10.64898/2026.10.14.759257}
}